Douglas Lin

18PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Liquid biopsiesMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 10, 2026
Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.

|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study.

|May 14, 2026
Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

|Feb 24, 2026
Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability.

Meera Mohan, Natalie Danziger, Othman Salim Akhtar

|Jan 15, 2026
Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic Implications.

Douglas I Lin, Elizabeth Lawrence, Natalie Danziger

|Dec 18, 2025
Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability.

Meera Mohan, Natalie Danziger, Othman Salim Akhtar

Pageof 3

Frequent Collaborators

7 joint publications

Jeffrey S Ross

5 joint publications

Natalie Danziger

4 joint publications

Richard S P Huang

4 joint publications

Ryon P Graf